Jonathan W. Chen
Corporate Officer/Principal presso MICROPORT SCIENTIFIC CORPORATION
Profilo
Attualmente, Jonathan W. Chen ricopre la posizione di Chief International Business Officer presso MicroPort Scientific Corp. È anche nel consiglio di Lombard Medical, Inc. e Promaxo, Inc. In passato ha occupato la posizione di vicepresidente senior per lo sviluppo commerciale di Angiotech Pharmaceuticals, Inc. e di banchiere d'investimento presso Credit Suisse First Boston Corp. Si è laureato alla Stanford University.
Posizioni attive di Jonathan W. Chen
Società | Posizione | Inizio |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/06/2021 |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Director/Board Member | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Chairman | 12/05/2023 |
Precedenti posizioni note di Jonathan W. Chen
Società | Posizione | Fine |
---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2011 |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | 01/05/2005 |
LOMBARD MEDICAL, INC. | Director/Board Member | - |
Formazione di Jonathan W. Chen
Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LOMBARD MEDICAL, INC. | Health Technology |
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
Aziende private | 4 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Credit Suisse First Boston Corp. | Finance |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
- Borsa valori
- Insiders
- Jonathan W. Chen